Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study

Figure 3 Kaplan-Meier survival analysis curves for United States and University of Texas Medical Branch cohorts. Hispanic/Latino patients are represented in red, while non-Hispanic/Latino patients are represented in blue. The four primary outcomes (all-cause mortality, hepatocellular carcinoma, type 2 diabetes mellitus, and fibrosis/cirrhosis of the liver) are represented for both cohorts. MASH: Metabolic dysfunction-associated steatohepatitis; UTMB: University of Texas Medical Branch; HCC: Hepatocellular carcinoma; T2DM: Type 2 diabetes mellitus.